The VA’s socialist paradise: the left used to love it

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
The VA’s socialist paradise: the left used to love it
By Rich Lowry
May 25, 2014 | 8:02pm


Photo: Reuters

For the left, the Department of Veterans Affairs is how health care is ideally supposed to work. No insurance companies, no private doctors, no competition — just the government and the patient.

New York Times columnist Paul Krugman has held up the VA as a model for the entire country. The Washington Monthly ran a famous article in 2005 arguing that the VA was leading the way for U.S. health care. The socialist senator from Vermont, Bernie Sanders, is such a reflexive defender that in an instantly notorious interview on CNN he pooh-poohed the burgeoning scandal that may involve fatalities with the undeniable observation that “people die every day.”

The VA is an island of socialism in American health care. It generally provides adequate care — to a limited universe of people and for only certain conditions — but has long been plagued by scandal. It is perhaps the worst bureaucracy in the federal government. As with all such single-payer-type systems, the cost of the notionally free health care is in the rationing, in this case the wait times that have had desperately ill vets hung out to dry for months.

The usual ObamaCare excuses don’t apply here. The existence of the VA isn’t politically controversial. No one is trying to repeal it, or “sabotage” it. What we’re seeing is simply unaccountable bureaucracy in action.

When the bench mark was created for VA facilities to get vets appointments within 14 days, meeting the goal was easy: All it took was logging appointments dishonestly to hide the wait time. This is how poorly performing government bureaucracies have met goals from time immemorial; it’s why, on a much more vast and monstrous scale, Soviet five-year plans were always such runaway successes on paper.

The VA system worked for everyone but the patients — and the whistle-blowers. The daughter-in-law of a Navy vet in Phoenix who died after never getting follow-up for his “urgent” case was told, in lines that perfectly capture the spirit of socialized medicine: “It’s a seven-month waiting list. And you’re gonna have to have patience.”

But the bureaucracy acted with alacrity when its reporting scheme was at risk. In St. Louis, the former chief of psychiatry says he was put under administrative investigation when he complained about wait lists. A whistle-blower who worked in Fort Collins, Colo., alleges that she and a colleague were transferred when they refused to hide wait times.

So far, the VA affair is running the usual course of Obama administration scandals, with the requisite denial and lack of accountability. VA Secretary Eric Shinseki has referred to the incidents as “isolated cases” (even though 26 facilities are now under investigation). No one has been fired. One of Shinseki’s deputies, Dr. Robert Petzel, resigned, but was scheduled to retire this year anyway. It was an appropriately Potemkin departure in a scandal involving Potemkin waiting lists.

The White House has reverted to its default position of maintaining that it doesn’t know much about what’s happening in the vast government it always wants to make bigger. Spokesman Jay Carney seemed to suggest the other day that the president first heard about the scandal from a CNN report. Pity the president having to wait for the coverage of missing Malaysia Airlines Flight 370 to die down before learning about malfeasance at his own VA.

Of course, the problem with wait times and the trustworthiness of the VA’s own reporting wasn’t news. The Government Accountability Office has been warning of it since 2000. It headlined a report published in December 2012, “VA HEALTH CARE: Reliability of Reported Outpatient Medical Appointment Wait Times and Scheduling Oversight Need Improvement.”

The VA obviously isn’t going anywhere, but the scandal should be the occasion for making it more transparent and accountable and giving vets more choices. As of now, it represents a case study in how a bureaucracy tends to its own interests, even at the expense of veterans relying on it for matters of life and death.

http://nypost.com/2014/05/25/the-vas-socialis...o-love-it/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 469

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 181

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 848

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 117

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 423

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 734

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

Updated Category News Views 51

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Continue Reading
WAVE Life Sciences: Rising Share Value Amid DMD Innovations

Updated Category News Views 50

Recent Developments at WAVE Life Sciences B.Riley has maintained a Buy rating on WAVE Life Sciences (NASDAQ: WVE) and raised the price target to $19 from $11. This adjustment comes after the promising announcement regarding the company's Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531. Promising DMD Drug Candidate The company's analyst highlighted an increase...

Continue Reading
First American Uranium Successfully Secures $2.86 Million Funding

Updated Category News Views 143

First American Uranium Secures Oversubscribed Financing First American Uranium Inc. is thrilled to announce the closing of its oversubscribed flow-through share financing, having raised an impressive $2.86 million from issuing a total of 2,073,262 flow-through shares. Each share was priced at $1.38, exceeding initial expectations. Funding Utilization for Exploration The...

Continue Reading
Community Healthcare Trust Reports Q2 Financial Results

Updated Category News Views 161

Summary of Financial Results Community Healthcare Trust Incorporated (NYSE: CHCT) recently announced its financial performance for the quarter ending June 30, 2025. The company reported a net loss of approximately $12.6 million or $0.50 per diluted common share. The funds from operations ("FFO") and adjusted funds from operations ("AFFO") during this period amounted to...

Continue Reading
Neuberger Fund Ups Distribution Amid Market Challenges

Updated Category News Views 169

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Continue Reading